Mpox: An emerging or re-emerging infection with a potential colossal burden on healthcare globally
Open Access
- 1 January 2025
- journal article
- review article
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 14 (1) , 12
Abstract
The World Health Organization identified mpox (formerly known as monkeypox), as a resurgent zoonotic epidemic caused by the mpox virus. It is an emerging and re-emerging pathogen with a range of hosts and geographical distribution worldwide. Peer-reviewed scientific articles from 1958 to 29 August 2024 related to global mpox research were extracted from Web of ScienceTM Core Collection and Google Scholar Databases to gauge the extent of the infection. Mpox is marked by a recent resurgence of infections across continents, with Africa being the hardest-hit region. The mpox re-emergence has shown a new mechanism of transmission, with several causes such as a rise in the number of unvaccinated individuals, behaviour risk factors, waning immunity, genetic evolution, and environmental circumstances. Preventive and control measures of mpox include vaccination and patient isolation, while treatment involves antivirals and antibiotics for secondary bacterial infections. Laboratory diagnosis entailing polymerase chain reaction can be effective for routine purposes, but results of serological tests must be interpreted with caution, because of cross-reacting determinants among orthopoxviruses. The structure and classification of the mpox virus, clinical manifestations, pathophysiology, epidemiology, historical antecedent, therapeutics, vaccines, and laboratory diagnosis of the disease are explicated, showcasing mpox as an emerging or re-emerging infection with a potential colossal burden on healthcare, and its classification as an international public health emergency by the World Health Organization. What this study adds: This review provides the global situation of mpox as an emerging or re-emerging infection, warranting its designation as an international public health emergency.Keywords
This publication has 130 references indexed in Scilit:
- A tale of two clades: monkeypox virusesJournal of General Virology, 2005
- Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus ChallengeThe Journal of Infectious Diseases, 2005
- Monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan® assays on the Roche LightCyclerLaboratory Investigation, 2004
- Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestationsJournal of the American Academy of Dermatology, 2004
- Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2003
- Enhanced Inhibition of Orthopoxvirus Replication In Vitro by Alkoxyalkyl Esters of Cidofovir and Cyclic CidofovirAntimicrobial Agents and Chemotherapy, 2002
- Cidofovir in the treatment of poxvirus infectionsAntiviral Research, 2002
- Loop-mediated isothermal amplification of DNANucleic Acids Research, 2000
- Re-emergence of monkeypox in Africa: a review of the past six yearsBritish Medical Bulletin, 1998
- A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.1972